Inventor · disambiguated record
Bharvin Kumar Patel
Also filed as: PATEL BHARVIN K · PATEL BHARVIN K R · PATEL BHARVIN KUMAR · PATEL BHARVIN KUMAR RAMESCHANDRA
10 granted patents·5 pending applications·164 citations·filing 2000–2020
88Inventor score
Top patents by PatentIndex Score
15 records- 0197US7541344B2Modulation of survivin expressionLILLY CO ELI·Filed 2004·Granted Jun 2, 2009·119 cites·24 claims
- 0288US10688104B2Combination therapy with Notch and PD-1 or PD-L1 inhibitorsLILLY CO ELI·Filed 2017·Granted Jun 23, 2020·6 cites·9 claims
- 0387US6368828B1Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and Stat6cUS HEALTH·Filed 2000·Granted Apr 9, 2002·17 cites·35 claims
- 0486US9000023B2Disubstituted phthalazine hedgehog pathway antagonistsHIPSKIND PHILIP ARTHUR·Filed 2012·Granted Apr 7, 2015·11 cites·6 claims
- 0581US8273742B2Disubstituted phthalazine hedgehog pathway antagonistsHIPSKIND PHILIP ARTHUR·Filed 2010·Granted Sep 25, 2012·6 cites·15 claims
- 0680US11826317B2Combination therapy with notch and PD-1 or PD-L1 inhibitorsLILLY CO ELI·Filed 2020·Granted Nov 28, 2023·1 cites·19 claims
- 0777US11564929B2Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancerLILLY CO ELI·Filed 2017·Granted Jan 31, 2023·1 cites·20 claims
- 0875US11298362B2Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancerLILLY CO ELI·Filed 2017·Granted Apr 12, 2022·3 cites·22 claims
- 0965US10787460B2(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7LILLY CO ELI·Filed 2019·Granted Sep 29, 2020·0 cites·17 claims
- 1063US2021032257A1(e)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting cdk7LILLY CO ELI·Filed 2020·Application pending·0 cites
- 1161US2009203896A1Modulation of survivin expressionBHAT BALKRISHEN·Filed 2009·Application pending·0 cites
- 1261US2009247611A1Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxelPATEL BHARVIN KUMAR·Filed 2009·Application pending·0 cites
- 1351US2007244065A1Composition Comprising a Survivin Oligonucleotide and Gemcitabine for The Treatment of CancerPATEL BHARVIN K·Filed 2005·Application pending·0 cites
- 1450US2012022140A1Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxelPATEL BHARVIN KUMAR·Filed 2011·Application pending·0 cites
- 1549US10450317B2Notch pathway signaling inhibitor compoundsLILLY CO ELI·Filed 2016·Granted Oct 22, 2019·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Bharvin Kumar Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →